Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 5.97565734 |
2 | neutrophil activation (GO:0042119) | 4.19230432 |
3 | regulation of platelet aggregation (GO:0090330) | 4.06550417 |
4 | thrombin receptor signaling pathway (GO:0070493) | 4.00674057 |
5 | positive regulation of mast cell activation (GO:0033005) | 3.96018039 |
6 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.93092184 |
7 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.85514444 |
8 | granulocyte activation (GO:0036230) | 3.82796214 |
9 | detection of other organism (GO:0098543) | 3.68941768 |
10 | positive regulation of B cell differentiation (GO:0045579) | 3.63441294 |
11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.58769654 |
12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.58769654 |
13 | detection of bacterium (GO:0016045) | 3.57975168 |
14 | response to peptidoglycan (GO:0032494) | 3.57968596 |
15 | regulation of mast cell degranulation (GO:0043304) | 3.53275170 |
16 | cellular extravasation (GO:0045123) | 3.45500507 |
17 | macrophage activation involved in immune response (GO:0002281) | 3.43244671 |
18 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.41061854 |
19 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.39438344 |
20 | myeloid cell activation involved in immune response (GO:0002275) | 3.37812603 |
21 | regulation of platelet activation (GO:0010543) | 3.33725836 |
22 | megakaryocyte development (GO:0035855) | 3.29156501 |
23 | response to host immune response (GO:0052572) | 3.28177473 |
24 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.28177473 |
25 | microglial cell activation (GO:0001774) | 3.26307751 |
26 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25570735 |
27 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.22918799 |
28 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.21505031 |
29 | leukocyte degranulation (GO:0043299) | 3.19044537 |
30 | regulation of mast cell activation (GO:0033003) | 3.18963832 |
31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.13767272 |
32 | regulation of RNA export from nucleus (GO:0046831) | 3.12985195 |
33 | positive regulation of histone deacetylation (GO:0031065) | 3.12370950 |
34 | mitotic sister chromatid cohesion (GO:0007064) | 3.12266599 |
35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.11200478 |
36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10899067 |
37 | angiogenesis involved in wound healing (GO:0060055) | 3.10816848 |
38 | regulation of regulatory T cell differentiation (GO:0045589) | 3.10721611 |
39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.09700022 |
40 | positive regulation of macrophage differentiation (GO:0045651) | 3.09491379 |
41 | regulation of leukocyte degranulation (GO:0043300) | 3.09305040 |
42 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.08657519 |
43 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08182762 |
44 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08182762 |
45 | positive regulation of lamellipodium assembly (GO:0010592) | 3.07088236 |
46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05780925 |
47 | response to host (GO:0075136) | 3.05780925 |
48 | response to host defenses (GO:0052200) | 3.05780925 |
49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.05691762 |
50 | detection of external biotic stimulus (GO:0098581) | 3.05248895 |
51 | trophectodermal cell differentiation (GO:0001829) | 3.04235299 |
52 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.03993431 |
53 | mRNA stabilization (GO:0048255) | 3.03650233 |
54 | RNA stabilization (GO:0043489) | 3.03650233 |
55 | platelet aggregation (GO:0070527) | 3.02339911 |
56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01209598 |
57 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.00126331 |
58 | negative regulation of cell killing (GO:0031342) | 3.00126331 |
59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.99566000 |
60 | lipoxygenase pathway (GO:0019372) | 2.98560623 |
61 | response to interleukin-15 (GO:0070672) | 2.98095162 |
62 | dendritic cell chemotaxis (GO:0002407) | 2.97115714 |
63 | pre-miRNA processing (GO:0031054) | 2.95927404 |
64 | adenosine receptor signaling pathway (GO:0001973) | 2.95858193 |
65 | regulation of B cell differentiation (GO:0045577) | 2.95107471 |
66 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.94478623 |
67 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.93200096 |
68 | NLS-bearing protein import into nucleus (GO:0006607) | 2.90215966 |
69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90114035 |
70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89830410 |
71 | negative regulation of histone methylation (GO:0031061) | 2.89228171 |
72 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88884891 |
73 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88884891 |
74 | T cell migration (GO:0072678) | 2.88360832 |
75 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.86758113 |
76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86020943 |
77 | positive regulation of mast cell degranulation (GO:0043306) | 2.86020943 |
78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84218466 |
79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.81153895 |
80 | germinal center formation (GO:0002467) | 2.80887850 |
81 | positive regulation by symbiont of host defense response (GO:0052509) | 2.80772847 |
82 | modulation by symbiont of host defense response (GO:0052031) | 2.80772847 |
83 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.80772847 |
84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.80772847 |
85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.80772847 |
86 | modulation by symbiont of host immune response (GO:0052553) | 2.80772847 |
87 | T cell selection (GO:0045058) | 2.80229734 |
88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79225006 |
89 | mitotic nuclear envelope disassembly (GO:0007077) | 2.78361439 |
90 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.76629459 |
91 | mast cell activation (GO:0045576) | 2.76421768 |
92 | nuclear pore complex assembly (GO:0051292) | 2.76369631 |
93 | detection of molecule of bacterial origin (GO:0032490) | 2.75913660 |
94 | positive regulation of B cell mediated immunity (GO:0002714) | 2.73392545 |
95 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.73392545 |
96 | macrophage activation (GO:0042116) | 2.72384418 |
97 | positive regulation of isotype switching (GO:0045830) | 2.72381099 |
98 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.71001843 |
99 | positive thymic T cell selection (GO:0045059) | 2.69882106 |
100 | leukocyte aggregation (GO:0070486) | 2.69276094 |
101 | regulation of protein heterodimerization activity (GO:0043497) | 2.68688079 |
102 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.67639750 |
103 | dendritic cell migration (GO:0036336) | 2.67635538 |
104 | negative regulation of interleukin-17 production (GO:0032700) | 2.67166575 |
105 | hepatocyte apoptotic process (GO:0097284) | 2.67100980 |
106 | T cell apoptotic process (GO:0070231) | 2.66757542 |
107 | response to muramyl dipeptide (GO:0032495) | 2.66669761 |
108 | positive regulation of lamellipodium organization (GO:1902745) | 2.65974897 |
109 | cellular response to type I interferon (GO:0071357) | 2.65081511 |
110 | type I interferon signaling pathway (GO:0060337) | 2.65081511 |
111 | membrane disassembly (GO:0030397) | 2.63624970 |
112 | nuclear envelope disassembly (GO:0051081) | 2.63624970 |
113 | corticosteroid receptor signaling pathway (GO:0031958) | 2.61541596 |
114 | regulation of gamma-delta T cell activation (GO:0046643) | 2.59086099 |
115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57983270 |
116 | regulation of translational fidelity (GO:0006450) | 2.57959449 |
117 | heterochromatin organization (GO:0070828) | 2.55947722 |
118 | immunoglobulin mediated immune response (GO:0016064) | 2.54895453 |
119 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.52806847 |
120 | actin nucleation (GO:0045010) | 2.50489967 |
121 | embryonic process involved in female pregnancy (GO:0060136) | 2.50190980 |
122 | establishment of endothelial barrier (GO:0061028) | 2.48848523 |
123 | nuclear pore organization (GO:0006999) | 2.47598579 |
124 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.46017620 |
125 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.44149445 |
126 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.43808022 |
127 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.41549263 |
128 | regulation of sister chromatid cohesion (GO:0007063) | 2.41383225 |
129 | nuclear envelope organization (GO:0006998) | 2.39991041 |
130 | regulation of early endosome to late endosome transport (GO:2000641) | 2.38909787 |
131 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.38440141 |
132 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.38237171 |
133 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.38218142 |
134 | cytokinetic process (GO:0032506) | 2.37712829 |
135 | histone H2A monoubiquitination (GO:0035518) | 2.37097580 |
136 | positive regulation of protein deacetylation (GO:0090312) | 2.37094624 |
137 | thymic T cell selection (GO:0045061) | 2.36888377 |
138 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.36724186 |
139 | lymphocyte apoptotic process (GO:0070227) | 2.36044201 |
140 | natural killer cell differentiation (GO:0001779) | 2.35608558 |
141 | response to UV-C (GO:0010225) | 2.34775758 |
142 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.34145230 |
143 | apoptotic process involved in morphogenesis (GO:0060561) | 2.32285637 |
144 | regulation of integrin activation (GO:0033623) | 2.31687265 |
145 | regulation of RNA stability (GO:0043487) | 2.30880281 |
146 | regulation of mRNA stability (GO:0043488) | 2.30813570 |
147 | embryonic hemopoiesis (GO:0035162) | 2.30778319 |
148 | tolerance induction (GO:0002507) | 2.28866337 |
149 | mitotic chromosome condensation (GO:0007076) | 2.28417436 |
150 | response to laminar fluid shear stress (GO:0034616) | 2.27360659 |
151 | protein localization to kinetochore (GO:0034501) | 2.26642882 |
152 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.25195684 |
153 | negative regulation of interleukin-12 production (GO:0032695) | 2.24132393 |
154 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.23400802 |
155 | regulation of spindle organization (GO:0090224) | 2.23290292 |
156 | endothelial tube morphogenesis (GO:0061154) | 2.23135807 |
157 | morphogenesis of an endothelium (GO:0003159) | 2.23135807 |
158 | histone mRNA catabolic process (GO:0071044) | 2.21856108 |
159 | B cell mediated immunity (GO:0019724) | 2.21506301 |
160 | positive regulation of interferon-alpha production (GO:0032727) | 2.21459316 |
161 | positive regulation of granulocyte differentiation (GO:0030854) | 2.21118875 |
162 | regulation of erythrocyte differentiation (GO:0045646) | 2.20769414 |
163 | negative thymic T cell selection (GO:0045060) | 2.19792478 |
164 | protein localization to endosome (GO:0036010) | 2.19160334 |
165 | leukocyte cell-cell adhesion (GO:0007159) | 2.19061046 |
166 | negative regulation of RNA splicing (GO:0033119) | 2.17429066 |
167 | B cell receptor signaling pathway (GO:0050853) | 2.17258162 |
168 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.16265720 |
169 | negative T cell selection (GO:0043383) | 2.15955716 |
170 | germ cell migration (GO:0008354) | 2.15866368 |
171 | regulation of mitotic spindle organization (GO:0060236) | 2.15270297 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.39396762 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.01719151 |
3 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.82675756 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 3.76553147 |
5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.28306383 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.14633878 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.00275812 |
8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65398906 |
9 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.54668374 |
10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50788939 |
11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.48031653 |
12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34498899 |
13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19266029 |
14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16575110 |
15 | MAF_26560356_Chip-Seq_TH1_Human | 2.15120109 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14325589 |
17 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.11308524 |
18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.08996418 |
19 | GATA1_19941826_ChIP-Seq_K562_Human | 2.08995423 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08750100 |
21 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.08678431 |
22 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.07746936 |
23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.05996029 |
24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98817108 |
25 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96259894 |
26 | MYB_26560356_Chip-Seq_TH2_Human | 1.96242489 |
27 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.92507568 |
28 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88254687 |
29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.86870805 |
30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86762454 |
31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.85520166 |
32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84725783 |
33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82994015 |
34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79306333 |
35 | MYB_26560356_Chip-Seq_TH1_Human | 1.77633014 |
36 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75369756 |
37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72920118 |
38 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.72034028 |
39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70963816 |
40 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70451775 |
41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69156183 |
42 | GATA2_19941826_ChIP-Seq_K562_Human | 1.67164620 |
43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.66580473 |
44 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.66026735 |
45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59624930 |
46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58092936 |
47 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.57585531 |
48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57315615 |
49 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54436602 |
50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53134626 |
51 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52024613 |
52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51941093 |
53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50887166 |
54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50070824 |
55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47860977 |
56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.44955870 |
57 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.43820551 |
58 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.43152486 |
59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.41888982 |
60 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40541322 |
61 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39267006 |
62 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39106669 |
63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.36338215 |
64 | MAF_26560356_Chip-Seq_TH2_Human | 1.35934438 |
65 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34878678 |
66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.34319013 |
67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33928963 |
68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33433598 |
69 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33323123 |
70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33308876 |
71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32020024 |
72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29990541 |
73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29858879 |
74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29607799 |
75 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27790954 |
76 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.27737889 |
77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27714460 |
78 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.27511335 |
79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.26293794 |
80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26242154 |
81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25883504 |
82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25408124 |
83 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.24583751 |
84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22987760 |
85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20689006 |
86 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.19975856 |
87 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18830329 |
88 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.17828244 |
89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16256501 |
90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15995087 |
91 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.15332444 |
92 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14915096 |
93 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14714041 |
94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14636897 |
95 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14446801 |
96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14318144 |
97 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13200662 |
98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12934505 |
99 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.11794632 |
100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11196302 |
101 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.10761808 |
102 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10711985 |
103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09440521 |
104 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07704999 |
105 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07637552 |
106 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06764668 |
107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06543285 |
108 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06028457 |
109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.05900289 |
110 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05874897 |
111 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05844899 |
112 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05571258 |
113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04727550 |
114 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03882871 |
115 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.03081382 |
116 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.03046663 |
117 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02992125 |
118 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.02958664 |
119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02874277 |
120 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02378617 |
121 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.01498515 |
122 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01327169 |
123 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01001692 |
124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99932714 |
125 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99694781 |
126 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98940420 |
127 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.98624671 |
128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98475303 |
129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98125497 |
130 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97649722 |
131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97198689 |
132 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96562765 |
133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95533763 |
134 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94511575 |
135 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93175338 |
136 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92705497 |
137 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90435366 |
138 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.88763337 |
139 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85935011 |
140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83928001 |
141 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83449049 |
142 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80478224 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.44471961 |
2 | MP0003303_peritoneal_inflammation | 3.12030136 |
3 | MP0010352_gastrointestinal_tract_polyps | 3.11269985 |
4 | MP0008004_abnormal_stomach_pH | 2.89361806 |
5 | MP0003300_gastrointestinal_ulcer | 2.77113620 |
6 | MP0003705_abnormal_hypodermis_morpholog | 2.64667050 |
7 | MP0002396_abnormal_hematopoietic_system | 2.48242821 |
8 | MP0002148_abnormal_hypersensitivity_rea | 2.43485852 |
9 | MP0009278_abnormal_bone_marrow | 2.38495730 |
10 | MP0005076_abnormal_cell_differentiation | 2.29584431 |
11 | MP0010234_abnormal_vibrissa_follicle | 2.15067070 |
12 | MP0004808_abnormal_hematopoietic_stem | 2.01530946 |
13 | MP0005397_hematopoietic_system_phenotyp | 2.00927513 |
14 | MP0001545_abnormal_hematopoietic_system | 2.00927513 |
15 | MP0003693_abnormal_embryo_hatching | 1.99013451 |
16 | MP0003566_abnormal_cell_adhesion | 1.94300691 |
17 | MP0003436_decreased_susceptibility_to | 1.91959373 |
18 | MP0010307_abnormal_tumor_latency | 1.89624520 |
19 | MP0004185_abnormal_adipocyte_glucose | 1.87880335 |
20 | MP0001800_abnormal_humoral_immune | 1.85074488 |
21 | MP0002877_abnormal_melanocyte_morpholog | 1.85056248 |
22 | MP0009333_abnormal_splenocyte_physiolog | 1.84149468 |
23 | MP0000490_abnormal_crypts_of | 1.80701649 |
24 | MP0003763_abnormal_thymus_physiology | 1.78267799 |
25 | MP0002398_abnormal_bone_marrow | 1.77920026 |
26 | MP0000685_abnormal_immune_system | 1.75377390 |
27 | MP0004264_abnormal_extraembryonic_tissu | 1.71224971 |
28 | MP0004947_skin_inflammation | 1.70640849 |
29 | MP0002452_abnormal_antigen_presenting | 1.68025608 |
30 | * MP0004957_abnormal_blastocyst_morpholog | 1.65773364 |
31 | MP0005023_abnormal_wound_healing | 1.64895971 |
32 | MP0003077_abnormal_cell_cycle | 1.63728204 |
33 | MP0003191_abnormal_cellular_cholesterol | 1.63272791 |
34 | MP0003111_abnormal_nucleus_morphology | 1.60284719 |
35 | MP0001790_abnormal_immune_system | 1.59550083 |
36 | MP0005387_immune_system_phenotype | 1.59550083 |
37 | MP0002166_altered_tumor_susceptibility | 1.57667600 |
38 | MP0010155_abnormal_intestine_physiology | 1.54623002 |
39 | MP0009764_decreased_sensitivity_to | 1.53337563 |
40 | MP0000350_abnormal_cell_proliferation | 1.53034589 |
41 | MP0001849_ear_inflammation | 1.52409449 |
42 | MP0001819_abnormal_immune_cell | 1.51895701 |
43 | MP0002420_abnormal_adaptive_immunity | 1.51859352 |
44 | MP0005000_abnormal_immune_tolerance | 1.50804807 |
45 | MP0005671_abnormal_response_to | 1.49270582 |
46 | MP0002405_respiratory_system_inflammati | 1.47564224 |
47 | MP0008260_abnormal_autophagy | 1.47324177 |
48 | MP0008961_abnormal_basal_metabolism | 1.47175061 |
49 | MP0002723_abnormal_immune_serum | 1.46648966 |
50 | MP0003172_abnormal_lysosome_physiology | 1.46367631 |
51 | MP0002722_abnormal_immune_system | 1.45514145 |
52 | MP0000703_abnormal_thymus_morphology | 1.45389742 |
53 | MP0000716_abnormal_immune_system | 1.44951983 |
54 | MP0006054_spinal_hemorrhage | 1.44813205 |
55 | MP0002006_tumorigenesis | 1.43856281 |
56 | MP0003866_abnormal_defecation | 1.42094606 |
57 | MP0001835_abnormal_antigen_presentation | 1.41298141 |
58 | MP0002132_abnormal_respiratory_system | 1.37739064 |
59 | MP0000689_abnormal_spleen_morphology | 1.37300420 |
60 | MP0003448_altered_tumor_morphology | 1.37149902 |
61 | MP0002998_abnormal_bone_remodeling | 1.36536466 |
62 | * MP0001730_embryonic_growth_arrest | 1.36305839 |
63 | MP0000733_abnormal_muscle_development | 1.34457644 |
64 | MP0002429_abnormal_blood_cell | 1.31689810 |
65 | MP0003091_abnormal_cell_migration | 1.31067055 |
66 | MP0005025_abnormal_response_to | 1.29901628 |
67 | MP0010094_abnormal_chromosome_stability | 1.29521392 |
68 | MP0000858_altered_metastatic_potential | 1.27586869 |
69 | MP0001915_intracranial_hemorrhage | 1.27104658 |
70 | * MP0002086_abnormal_extraembryonic_tissu | 1.25861618 |
71 | MP0003075_altered_response_to | 1.24905254 |
72 | MP0000465_gastrointestinal_hemorrhage | 1.21741625 |
73 | MP0001533_abnormal_skeleton_physiology | 1.21205926 |
74 | MP0002019_abnormal_tumor_incidence | 1.19027072 |
75 | MP0004510_myositis | 1.18366695 |
76 | MP0003453_abnormal_keratinocyte_physiol | 1.18247083 |
77 | MP0004381_abnormal_hair_follicle | 1.17398342 |
78 | MP0003984_embryonic_growth_retardation | 1.16150682 |
79 | MP0002419_abnormal_innate_immunity | 1.13974859 |
80 | MP0005464_abnormal_platelet_physiology | 1.13730196 |
81 | MP0002088_abnormal_embryonic_growth/wei | 1.13448815 |
82 | MP0006082_CNS_inflammation | 1.12549853 |
83 | MP0005310_abnormal_salivary_gland | 1.10874784 |
84 | MP0008469_abnormal_protein_level | 1.10778571 |
85 | * MP0001697_abnormal_embryo_size | 1.10770215 |
86 | MP0009763_increased_sensitivity_to | 1.10533346 |
87 | MP0001663_abnormal_digestive_system | 1.09223567 |
88 | MP0009785_altered_susceptibility_to | 1.09206493 |
89 | MP0005380_embryogenesis_phenotype | 1.08774494 |
90 | MP0001672_abnormal_embryogenesis/_devel | 1.08774494 |
91 | MP0005083_abnormal_biliary_tract | 1.08610137 |
92 | MP0003656_abnormal_erythrocyte_physiolo | 1.08312834 |
93 | MP0001873_stomach_inflammation | 1.06183850 |
94 | MP0004130_abnormal_muscle_cell | 1.05029634 |
95 | MP0000249_abnormal_blood_vessel | 1.05028008 |
96 | MP0005451_abnormal_body_composition | 1.04517165 |
97 | MP0004883_abnormal_blood_vessel | 1.03850404 |
98 | * MP0002084_abnormal_developmental_patter | 1.02336619 |
99 | MP0001845_abnormal_inflammatory_respons | 1.02077697 |
100 | MP0001851_eye_inflammation | 1.01638941 |
101 | MP0005058_abnormal_lysosome_morphology | 1.00606086 |
102 | MP0000477_abnormal_intestine_morphology | 0.99285011 |
103 | MP0002925_abnormal_cardiovascular_devel | 0.99145183 |
104 | MP0005166_decreased_susceptibility_to | 0.98981147 |
105 | MP0002653_abnormal_ependyma_morphology | 0.98896354 |
106 | * MP0002080_prenatal_lethality | 0.97800827 |
107 | MP0003045_fibrosis | 0.97327356 |
108 | MP0003183_abnormal_peptide_metabolism | 0.94851612 |
109 | * MP0002085_abnormal_embryonic_tissue | 0.93312457 |
110 | MP0008874_decreased_physiological_sensi | 0.92661017 |
111 | MP0005621_abnormal_cell_physiology | 0.91826219 |
112 | MP0001853_heart_inflammation | 0.91455637 |
113 | MP0000015_abnormal_ear_pigmentation | 0.88743611 |
114 | MP0000313_abnormal_cell_death | 0.88260405 |
115 | MP0009765_abnormal_xenobiotic_induced | 0.84721824 |
116 | MP0005257_abnormal_intraocular_pressure | 0.83013556 |
117 | MP0005164_abnormal_response_to | 0.82744679 |
118 | MP0005390_skeleton_phenotype | 0.82398032 |
119 | MP0008057_abnormal_DNA_replication | 0.82211862 |
120 | MP0002089_abnormal_postnatal_growth/wei | 0.81903141 |
121 | MP0008007_abnormal_cellular_replicative | 0.81869307 |
122 | MP0004197_abnormal_fetal_growth/weight/ | 0.80657640 |
123 | MP0009840_abnormal_foam_cell | 0.78956481 |
124 | MP0005167_abnormal_blood-brain_barrier | 0.78955996 |
125 | MP0000537_abnormal_urethra_morphology | 0.77464377 |
126 | MP0003828_pulmonary_edema | 0.76456393 |
127 | MP0000343_altered_response_to | 0.75179453 |
128 | MP0003638_abnormal_response/metabolism_ | 0.73791967 |
129 | MP0003279_aneurysm | 0.72695382 |
130 | MP0003795_abnormal_bone_structure | 0.70949201 |
131 | MP0005409_darkened_coat_color | 0.66963992 |
132 | MP0005165_increased_susceptibility_to | 0.66815475 |
133 | MP0000230_abnormal_systemic_arterial | 0.64739377 |
134 | MP0005381_digestive/alimentary_phenotyp | 0.64472291 |
135 | MP0003806_abnormal_nucleotide_metabolis | 0.63555578 |
136 | MP0005535_abnormal_body_temperature | 0.59732711 |
137 | MP0003690_abnormal_glial_cell | 0.59162846 |
138 | MP0004484_altered_response_of | 0.58286665 |
139 | MP0003879_abnormal_hair_cell | 0.57248597 |
140 | MP0004084_abnormal_cardiac_muscle | 0.56613230 |
141 | MP0005666_abnormal_adipose_tissue | 0.55430126 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged bleeding time (HP:0003010) | 7.69633909 |
2 | Abnormal platelet volume (HP:0011876) | 6.04609286 |
3 | Purpura (HP:0000979) | 6.01288852 |
4 | Menorrhagia (HP:0000132) | 5.88183580 |
5 | Increased mean platelet volume (HP:0011877) | 5.86240355 |
6 | Epistaxis (HP:0000421) | 5.56394268 |
7 | Gingival bleeding (HP:0000225) | 5.10217857 |
8 | Spontaneous hematomas (HP:0007420) | 4.66977125 |
9 | Abnormality of macrophages (HP:0004311) | 4.33355379 |
10 | Stomatitis (HP:0010280) | 4.12798092 |
11 | Abnormal platelet function (HP:0011869) | 3.84662574 |
12 | Impaired platelet aggregation (HP:0003540) | 3.84662574 |
13 | Obstructive lung disease (HP:0006536) | 3.55417748 |
14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.55417748 |
15 | Abnormality of the fingertips (HP:0001211) | 3.51920659 |
16 | Orchitis (HP:0100796) | 3.42607326 |
17 | Autoimmune thrombocytopenia (HP:0001973) | 3.29093215 |
18 | Encephalitis (HP:0002383) | 3.18218218 |
19 | Optic neuritis (HP:0100653) | 3.10630973 |
20 | Retrobulbar optic neuritis (HP:0100654) | 3.10630973 |
21 | Meningitis (HP:0001287) | 2.98547659 |
22 | Recurrent viral infections (HP:0004429) | 2.91900086 |
23 | Chest pain (HP:0100749) | 2.91719958 |
24 | Increased IgM level (HP:0003496) | 2.84858916 |
25 | Gastrointestinal infarctions (HP:0005244) | 2.83425665 |
26 | Vasculitis (HP:0002633) | 2.83148707 |
27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.81913933 |
28 | Increased density of long bones (HP:0006392) | 2.81726996 |
29 | Cellulitis (HP:0100658) | 2.78074554 |
30 | Hyperlipoproteinemia (HP:0010980) | 2.78027479 |
31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.77590408 |
32 | Recurrent skin infections (HP:0001581) | 2.70951200 |
33 | Arterial thrombosis (HP:0004420) | 2.67055139 |
34 | Autoimmune hemolytic anemia (HP:0001890) | 2.66675800 |
35 | Recurrent fungal infections (HP:0002841) | 2.65253803 |
36 | Eczematoid dermatitis (HP:0000976) | 2.60268702 |
37 | Pustule (HP:0200039) | 2.52003013 |
38 | Gingivitis (HP:0000230) | 2.50945715 |
39 | Bruising susceptibility (HP:0000978) | 2.50624789 |
40 | Chronic otitis media (HP:0000389) | 2.50535981 |
41 | Urticaria (HP:0001025) | 2.49768514 |
42 | Hepatosplenomegaly (HP:0001433) | 2.49539653 |
43 | Hematochezia (HP:0002573) | 2.48767053 |
44 | Recurrent abscess formation (HP:0002722) | 2.47347874 |
45 | Panhypogammaglobulinemia (HP:0003139) | 2.47061811 |
46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.44310005 |
47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.44310005 |
48 | Episodic fever (HP:0001954) | 2.43298326 |
49 | Joint swelling (HP:0001386) | 2.40722894 |
50 | Genu recurvatum (HP:0002816) | 2.40031624 |
51 | Granulocytopenia (HP:0001913) | 2.38882267 |
52 | Interstitial pulmonary disease (HP:0006530) | 2.36102777 |
53 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.36086120 |
54 | Cerebral aneurysm (HP:0004944) | 2.35168526 |
55 | Spondylolisthesis (HP:0003302) | 2.34856622 |
56 | Keratoconjunctivitis sicca (HP:0001097) | 2.31110917 |
57 | Conjunctival telangiectasia (HP:0000524) | 2.30461702 |
58 | Volvulus (HP:0002580) | 2.28268263 |
59 | Abnormality of iron homeostasis (HP:0011031) | 2.25700933 |
60 | Prominent nose (HP:0000448) | 2.24974298 |
61 | Recurrent bacterial skin infections (HP:0005406) | 2.24731884 |
62 | Sparse lateral eyebrow (HP:0005338) | 2.22626905 |
63 | Rectal prolapse (HP:0002035) | 2.21268301 |
64 | Shallow orbits (HP:0000586) | 2.20512191 |
65 | Aortic aneurysm (HP:0004942) | 2.20178869 |
66 | Acute myeloid leukemia (HP:0004808) | 2.18895516 |
67 | Poikilocytosis (HP:0004447) | 2.18693432 |
68 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.18660235 |
69 | Dysostosis multiplex (HP:0000943) | 2.18352055 |
70 | Increased serum ferritin (HP:0003281) | 2.15847104 |
71 | Pulmonary infiltrates (HP:0002113) | 2.15704801 |
72 | Long eyelashes (HP:0000527) | 2.14641775 |
73 | Pulmonary embolism (HP:0002204) | 2.14344735 |
74 | Ulnar bowing (HP:0003031) | 2.14215350 |
75 | Verrucae (HP:0200043) | 2.10654477 |
76 | Papilloma (HP:0012740) | 2.10654477 |
77 | Increased IgE level (HP:0003212) | 2.10172244 |
78 | Deviation of the thumb (HP:0009603) | 2.09698314 |
79 | Keratoconjunctivitis (HP:0001096) | 2.09431031 |
80 | Macroorchidism (HP:0000053) | 2.09092920 |
81 | Hypergammaglobulinemia (HP:0010702) | 2.08296296 |
82 | Disinhibition (HP:0000734) | 2.07751567 |
83 | Proximal placement of thumb (HP:0009623) | 2.07587873 |
84 | T lymphocytopenia (HP:0005403) | 2.06320545 |
85 | Pili torti (HP:0003777) | 2.04456068 |
86 | Abnormality of the common coagulation pathway (HP:0010990) | 2.03869169 |
87 | Hemoptysis (HP:0002105) | 2.01731029 |
88 | Vertigo (HP:0002321) | 2.01371468 |
89 | Eosinophilia (HP:0001880) | 2.00918647 |
90 | Blepharitis (HP:0000498) | 2.00851703 |
91 | IgM deficiency (HP:0002850) | 2.00768576 |
92 | Emphysema (HP:0002097) | 1.98060211 |
93 | Microcytic anemia (HP:0001935) | 1.98046500 |
94 | Short 1st metacarpal (HP:0010034) | 1.97819941 |
95 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.97819941 |
96 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.97579311 |
97 | Gastrointestinal carcinoma (HP:0002672) | 1.97579311 |
98 | Polycythemia (HP:0001901) | 1.97392287 |
99 | Osteomyelitis (HP:0002754) | 1.97234156 |
100 | Agammaglobulinemia (HP:0004432) | 1.96936384 |
101 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.96364956 |
102 | Thrombocytosis (HP:0001894) | 1.95586487 |
103 | Basal cell carcinoma (HP:0002671) | 1.95363709 |
104 | Nasal polyposis (HP:0100582) | 1.95188680 |
105 | Hypochromic microcytic anemia (HP:0004840) | 1.94389047 |
106 | Acanthocytosis (HP:0001927) | 1.94273929 |
107 | Abnormality of T cell physiology (HP:0011840) | 1.93407223 |
108 | Narrow palate (HP:0000189) | 1.92357167 |
109 | Increased cerebral lipofuscin (HP:0011813) | 1.91558783 |
110 | Abnormality of T cell number (HP:0011839) | 1.90968250 |
111 | Mediastinal lymphadenopathy (HP:0100721) | 1.90435923 |
112 | Protrusio acetabuli (HP:0003179) | 1.87512779 |
113 | IgA deficiency (HP:0002720) | 1.86317610 |
114 | Abnormality of the nasal mucosa (HP:0000433) | 1.85901251 |
115 | Gangrene (HP:0100758) | 1.85371584 |
116 | Anorexia (HP:0002039) | 1.84598277 |
117 | Subacute progressive viral hepatitis (HP:0006572) | 1.84512321 |
118 | Glomerulopathy (HP:0100820) | 1.83515193 |
119 | Recurrent bronchitis (HP:0002837) | 1.82719790 |
120 | Gastrointestinal inflammation (HP:0004386) | 1.82416900 |
121 | Myositis (HP:0100614) | 1.81023438 |
122 | Amyloidosis (HP:0011034) | 1.80928652 |
123 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.80572924 |
124 | Hypochromic anemia (HP:0001931) | 1.80111758 |
125 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.79679190 |
126 | Lymphopenia (HP:0001888) | 1.79395993 |
127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79245516 |
128 | Colitis (HP:0002583) | 1.79216246 |
129 | Arthralgia (HP:0002829) | 1.79189905 |
130 | Amaurosis fugax (HP:0100576) | 1.77432833 |
131 | Hyperacusis (HP:0010780) | 1.77201003 |
132 | Short phalanx of the thumb (HP:0009660) | 1.76568071 |
133 | Inflammation of the large intestine (HP:0002037) | 1.76547537 |
134 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.76463650 |
135 | Fatigue (HP:0012378) | 1.75253136 |
136 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.74700511 |
137 | Broad palm (HP:0001169) | 1.73828190 |
138 | Abnormality of the 1st metacarpal (HP:0010009) | 1.73316859 |
139 | Papilledema (HP:0001085) | 1.69897950 |
140 | Aneurysm (HP:0002617) | 1.69738159 |
141 | Increased nuchal translucency (HP:0010880) | 1.68213279 |
142 | Mitral valve prolapse (HP:0001634) | 1.68210808 |
143 | Bladder carcinoma (HP:0002862) | 1.67987020 |
144 | Bladder neoplasm (HP:0009725) | 1.67987020 |
145 | Limited elbow extension (HP:0001377) | 1.65860542 |
146 | Facial hemangioma (HP:0000329) | 1.64553238 |
147 | Somatic mutation (HP:0001428) | 1.64479190 |
148 | Uterine leiomyosarcoma (HP:0002891) | 1.63879450 |
149 | Leiomyosarcoma (HP:0100243) | 1.63879450 |
150 | Combined immunodeficiency (HP:0005387) | 1.63713963 |
151 | Bicuspid aortic valve (HP:0001647) | 1.63085402 |
152 | Abnormality of T cells (HP:0002843) | 1.63002433 |
153 | Urethral obstruction (HP:0000796) | 1.62218385 |
154 | High pitched voice (HP:0001620) | 1.61230833 |
155 | Persistence of primary teeth (HP:0006335) | 1.60806875 |
156 | Broad thumb (HP:0011304) | 1.60691860 |
157 | Abnormality of the peritoneum (HP:0002585) | 1.59094545 |
158 | Skin tags (HP:0010609) | 1.57474957 |
159 | Petechiae (HP:0000967) | 1.57335833 |
160 | Gastrointestinal stroma tumor (HP:0100723) | 1.57042408 |
161 | Leukocytosis (HP:0001974) | 1.56781862 |
162 | Short 4th metacarpal (HP:0010044) | 1.56773728 |
163 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.56773728 |
164 | Dilatation of the ascending aorta (HP:0005111) | 1.56316958 |
165 | Ependymoma (HP:0002888) | 1.56011105 |
166 | Aortic dissection (HP:0002647) | 1.55212514 |
167 | Thyroiditis (HP:0100646) | 1.54389312 |
168 | Cervical subluxation (HP:0003308) | 1.53663246 |
169 | Annular pancreas (HP:0001734) | 1.53515414 |
170 | Dysmetric saccades (HP:0000641) | 1.53031911 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 5.47772931 |
2 | EEF2K | 3.31277703 |
3 | CDK12 | 3.15617259 |
4 | TRIB3 | 3.09734481 |
5 | MAP4K1 | 2.89792257 |
6 | STK10 | 2.76607153 |
7 | TAOK1 | 2.57262628 |
8 | LATS1 | 2.33990406 |
9 | MAP3K10 | 2.33530866 |
10 | FES | 2.31168265 |
11 | PKN2 | 2.26223762 |
12 | ERN1 | 2.25024986 |
13 | LRRK2 | 2.21655726 |
14 | PRPF4B | 2.19724132 |
15 | DMPK | 1.99645084 |
16 | IRAK4 | 1.93177720 |
17 | RPS6KA4 | 1.78455755 |
18 | TNK2 | 1.74786349 |
19 | STK3 | 1.66903568 |
20 | TAOK3 | 1.66623695 |
21 | SIK3 | 1.64233137 |
22 | TYK2 | 1.59063389 |
23 | BMPR2 | 1.55486362 |
24 | ALK | 1.53089958 |
25 | MAP3K3 | 1.45966678 |
26 | KSR2 | 1.45662802 |
27 | JAK3 | 1.45290049 |
28 | CDC7 | 1.44555700 |
29 | EPHB1 | 1.40837123 |
30 | NEK2 | 1.39979974 |
31 | RIPK1 | 1.38692194 |
32 | MAP3K14 | 1.35687834 |
33 | LYN | 1.35221233 |
34 | CDK6 | 1.34061158 |
35 | MAP3K9 | 1.31048239 |
36 | GRK6 | 1.29451608 |
37 | CSK | 1.26213130 |
38 | PAK4 | 1.25702076 |
39 | PIK3CG | 1.21104239 |
40 | PTK6 | 1.19647293 |
41 | IKBKB | 1.18967128 |
42 | CAMK1D | 1.16751847 |
43 | ZAP70 | 1.16530104 |
44 | ITK | 1.16065439 |
45 | KIT | 1.16037262 |
46 | BMX | 1.12994309 |
47 | LATS2 | 1.12878989 |
48 | PTK2B | 1.12607006 |
49 | TESK2 | 1.10377637 |
50 | MAP3K8 | 1.08491514 |
51 | JAK1 | 1.08111970 |
52 | FGFR3 | 1.06142492 |
53 | TAOK2 | 1.05749934 |
54 | PIM2 | 1.00606184 |
55 | PDK1 | 0.99048203 |
56 | RPS6KB2 | 0.98639388 |
57 | MYLK | 0.97923720 |
58 | PIM1 | 0.97847837 |
59 | TBK1 | 0.97702813 |
60 | CDK4 | 0.96979529 |
61 | MAP3K6 | 0.95130494 |
62 | HIPK2 | 0.94411296 |
63 | BLK | 0.93981242 |
64 | MAP3K13 | 0.93977752 |
65 | GRK5 | 0.93975394 |
66 | MTOR | 0.90696530 |
67 | RAF1 | 0.89435793 |
68 | IRAK1 | 0.88990913 |
69 | TYRO3 | 0.88612759 |
70 | MATK | 0.87395025 |
71 | IRAK3 | 0.87355547 |
72 | CAMK1G | 0.87131617 |
73 | PDGFRA | 0.86063186 |
74 | BTK | 0.85767261 |
75 | TXK | 0.80043269 |
76 | PDPK1 | 0.79887536 |
77 | MAPK12 | 0.77478326 |
78 | CDK7 | 0.77172562 |
79 | PRKD2 | 0.77028334 |
80 | FGFR4 | 0.75571290 |
81 | IRAK2 | 0.75228573 |
82 | SCYL2 | 0.73679877 |
83 | MST4 | 0.73387457 |
84 | YES1 | 0.72755158 |
85 | HCK | 0.72120953 |
86 | SIK2 | 0.69981589 |
87 | MARK3 | 0.69845607 |
88 | CDK9 | 0.69321282 |
89 | CAMKK2 | 0.68788022 |
90 | SIK1 | 0.68695862 |
91 | RET | 0.68642407 |
92 | MAP3K11 | 0.68237660 |
93 | EIF2AK1 | 0.67444736 |
94 | PDGFRB | 0.66810517 |
95 | TTK | 0.65477899 |
96 | NLK | 0.64362534 |
97 | PTK2 | 0.64346465 |
98 | JAK2 | 0.63792023 |
99 | SYK | 0.63309646 |
100 | LCK | 0.58341560 |
101 | DYRK1B | 0.56877140 |
102 | MAPKAPK3 | 0.56195744 |
103 | CSF1R | 0.55428825 |
104 | SMG1 | 0.55412727 |
105 | CDC42BPA | 0.54793994 |
106 | PRKCQ | 0.54493672 |
107 | PAK2 | 0.53719412 |
108 | TTN | 0.53650713 |
109 | MARK2 | 0.52609642 |
110 | MAP3K5 | 0.52449539 |
111 | * FYN | 0.50867627 |
112 | FLT3 | 0.50382196 |
113 | SGK3 | 0.49863316 |
114 | MELK | 0.49646868 |
115 | CHUK | 0.49193879 |
116 | CHEK2 | 0.48464921 |
117 | MAPKAPK2 | 0.48204993 |
118 | TGFBR2 | 0.47590559 |
119 | TEC | 0.46732596 |
120 | ILK | 0.46412649 |
121 | CHEK1 | 0.45771799 |
122 | EGFR | 0.45684947 |
123 | MAP3K2 | 0.45258108 |
124 | PAK1 | 0.45205494 |
125 | FGR | 0.45030511 |
126 | CAMKK1 | 0.43686162 |
127 | MAP2K3 | 0.43130638 |
128 | CDK2 | 0.42807980 |
129 | MAP3K1 | 0.42590027 |
130 | MAPK7 | 0.41914241 |
131 | MAPK11 | 0.41808931 |
132 | ICK | 0.41530932 |
133 | DDR2 | 0.40909486 |
134 | GRK7 | 0.39695668 |
135 | TGFBR1 | 0.39604205 |
136 | RPS6KA1 | 0.38619791 |
137 | SGK2 | 0.37272712 |
138 | PRKD1 | 0.36258405 |
139 | MAP3K7 | 0.36174061 |
140 | IKBKE | 0.35768469 |
141 | RPS6KC1 | 0.35362232 |
142 | RPS6KL1 | 0.35362232 |
143 | KDR | 0.35159723 |
144 | EPHA3 | 0.35072838 |
145 | ARAF | 0.34694506 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00829536 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98918923 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 1.97206213 |
4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83848709 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82882170 |
6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.82112511 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.77628942 |
8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77013630 |
9 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.65411464 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60675749 |
11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59059185 |
12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58259995 |
13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55031949 |
14 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.50459563 |
15 | Colorectal cancer_Homo sapiens_hsa05210 | 1.46203235 |
16 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.43332078 |
17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43264188 |
18 | Hepatitis B_Homo sapiens_hsa05161 | 1.40054820 |
19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40016506 |
20 | Shigellosis_Homo sapiens_hsa05131 | 1.39616028 |
21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.36956898 |
22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.36205981 |
23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35346965 |
24 | Adherens junction_Homo sapiens_hsa04520 | 1.35277986 |
25 | Asthma_Homo sapiens_hsa05310 | 1.34473589 |
26 | Measles_Homo sapiens_hsa05162 | 1.33170201 |
27 | Cell cycle_Homo sapiens_hsa04110 | 1.30172938 |
28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.29373646 |
29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28268123 |
30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28153212 |
31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28060013 |
32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27612739 |
33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27357370 |
34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.27173545 |
35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.26364280 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24464823 |
37 | Phagosome_Homo sapiens_hsa04145 | 1.19943883 |
38 | * Small cell lung cancer_Homo sapiens_hsa05222 | 1.19612478 |
39 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.18788791 |
40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17636768 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16774518 |
42 | Thyroid cancer_Homo sapiens_hsa05216 | 1.15149983 |
43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15123248 |
44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14826122 |
45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14777802 |
46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11197589 |
47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10957227 |
48 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.10021526 |
49 | Influenza A_Homo sapiens_hsa05164 | 1.08026418 |
50 | Apoptosis_Homo sapiens_hsa04210 | 1.07850110 |
51 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07496096 |
52 | Tuberculosis_Homo sapiens_hsa05152 | 1.06093725 |
53 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04157811 |
54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.02503417 |
55 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.02180810 |
56 | Platelet activation_Homo sapiens_hsa04611 | 1.02129655 |
57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02062175 |
58 | Bladder cancer_Homo sapiens_hsa05219 | 1.01154133 |
59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01121430 |
60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00391950 |
61 | Glioma_Homo sapiens_hsa05214 | 0.99777431 |
62 | RNA transport_Homo sapiens_hsa03013 | 0.99439476 |
63 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.98662335 |
64 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98626716 |
65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98621466 |
66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97686609 |
67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94292592 |
68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94239591 |
69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92917122 |
70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92689044 |
71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92175073 |
72 | Prostate cancer_Homo sapiens_hsa05215 | 0.91460905 |
73 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91273266 |
74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88022509 |
75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87114588 |
76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86582865 |
77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85656273 |
78 | Focal adhesion_Homo sapiens_hsa04510 | 0.85144994 |
79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83614720 |
80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82708860 |
81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82011848 |
82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81432962 |
83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.80405111 |
84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80337695 |
85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80114165 |
86 | Salmonella infection_Homo sapiens_hsa05132 | 0.79882527 |
87 | Endocytosis_Homo sapiens_hsa04144 | 0.79377343 |
88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77978083 |
89 | Hepatitis C_Homo sapiens_hsa05160 | 0.77060359 |
90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76839181 |
91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76093912 |
92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75731647 |
93 | Legionellosis_Homo sapiens_hsa05134 | 0.75056377 |
94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74493979 |
95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73918164 |
96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73612310 |
97 | Amoebiasis_Homo sapiens_hsa05146 | 0.73550651 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73536528 |
99 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.72352090 |
100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71762503 |
101 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71579526 |
102 | Base excision repair_Homo sapiens_hsa03410 | 0.70171667 |
103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69880332 |
104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69788684 |
105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69538747 |
106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69118558 |
107 | Malaria_Homo sapiens_hsa05144 | 0.68225465 |
108 | Lysosome_Homo sapiens_hsa04142 | 0.68098859 |
109 | Pertussis_Homo sapiens_hsa05133 | 0.67341928 |
110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67058154 |
111 | RNA degradation_Homo sapiens_hsa03018 | 0.66660758 |
112 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.66378872 |
113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64791030 |
114 | Insulin resistance_Homo sapiens_hsa04931 | 0.64672324 |
115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63814547 |
116 | Spliceosome_Homo sapiens_hsa03040 | 0.63253602 |
117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62843408 |
118 | DNA replication_Homo sapiens_hsa03030 | 0.62602658 |
119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60782331 |
120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59699326 |
121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59185252 |
122 | Mineral absorption_Homo sapiens_hsa04978 | 0.57548386 |
123 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56631183 |
124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56466161 |
125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.55544790 |
126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55215043 |
127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53996188 |
128 | Gap junction_Homo sapiens_hsa04540 | 0.53821480 |
129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51020321 |
130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48707904 |
131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46839603 |
132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46078585 |
133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41346889 |